The global chemical face peels products market, valued at USD 1.8 billion in 2025, is projected to reach USD 3.5 billion by 2034 at a CAGR of 7.2%. Growth is driven by rising demand for non-invasive skincare treatments, formulation innovations, and increasing consumer focus on skin health and aesthetics.
Read MoreThe global acellular dermal matrix (ADM) market, valued at USD 1.42 billion in 2025, is projected to reach USD 2.78 billion by 2034 at a CAGR of 7.5%. Growth is driven by rising reconstructive surgeries, advancements in wound care, and increasing adoption of biologic matrices in regenerative medicine
Read MoreThe global Exelon Patch market is witnessing steady growth driven by rising dementia cases, increasing adoption of transdermal drug delivery systems, and advancements in neurological treatment solutions.
Read MoreThe global targeted drugs for multiple sclerosis market, valued at USD 27.5 billion in 2025, is projected to reach USD 42.3 billion by 2034 at a CAGR of 4.7%. Growth is driven by rising MS prevalence, advancements in precision therapies, and increasing adoption of targeted disease-modifying treatments.
Read More